+ Filter



N. meningitidis fHbp

Anti-N. meningitidis fHbp Products
-
- Species Reactivity: N. meningitidis
- Type: Human IgG
- Application: ELISA, SPR
-
- Species Reactivity: N. meningitidis serogroup B (MenB)
- Type: Human IgG1
- Application: SPR, ELISA, FC
-
- Species Reactivity: N. meningitidis serogroup B (MenB)
- Type: Human Fab
- Application: ELISA, FC
-
- Species Reactivity: N. meningitidis serogroup B (MenB)
- Type: Human scFv
- Application: ELISA, FC
-
- Species Reactivity: N. meningitidis serogroup B (strain MC58)
- Type: Human IgG
- Application: FC, Inhib
-
- Species Reactivity: N. meningitidis
- Type: Human IgG1, scFv-Fc
- Application: IA
- DrugMonitor™ Anti-N. meningitidis fhbp Antibody (VS-1224-YC1742) (VS-1224-YC1742)
-
- Specificity: N. meningitidis fhbp
- Species Reactivity: N. meningitidis serogroup b
- Type: Mouse IgG
- Application: ELISA, PK/PD, ADA control
-
- Species Reactivity: N. meningitidis
- Target: N. meningitidis fHbp
- Type: Tandem scFv
- Application: Block, ELISA, FC, WB
View More Products
Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag
More Infomation
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
For Research Use Only. Not For Clinical Use.
Background
A bacterial surface lipoprotein that binds host (human) complement factor H (fH, gene CFH), binding contributes to the avoidance of complement-mediated lysis by N.meningitidis. Binding of fH to the bacteria surface is independent of bacterial sialic acid moieties.
Factor H binding protein (fHbp) that is exhibited in N. meningitidis and some commensal species is the main inhibitor of the alternative complement pathway. fHbp protects meningococci from complement-mediated death in human serum experiments, but has also been shown to protect meningococci from antimicrobial peptides in vitro. Factor H binding protein is key to the pathogenesis of N. meningitidis, and is, therefore, important as a potential vaccine candidate.